Use of direct thrombin inhibitor for treatment of cerebral venous thrombosis

Journal of Stroke and Cerebrovascular Diseases

Volumn 21, Issue 8, 2012, Pages 915.e11-915.e15

  Hon, Sonny Fong Kwong ^a   Li, Ho Lun Terrance ^a   Cheng, Pui Wai ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Anticoagulation; cerebral venous thrombosis; dabigatran; Pradaxa; sinus vein thrombosis; warfarin; young stroke

Indexed keywords

EID: 84868372521     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2012.02.004     Document Type: Article

References (12)

1. M.G. Bousser, and J.M. Ferro Cerebral venous thrombosis: An update Lancet Neurol 6 2007 162 170
2. W.M. van den Bergh, I. van der Schaaf, and J. van Gijn The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis Neurology 65 2005 192 196
3. T.J. Vogl, C. Bergman, and A. Villringer Dural sinus thrombosis: Value of venous MR angiography for diagnosis and follow-up AJR Am J Roentgenol 162 1994 1191 1198
4. J. Kimber Cerebral venous sinus thrombosis QJM 95 2002 137 142
5. K.M. Einhäupl, A. Villringer, and W. Meister Heparin treatment in sinus venous thrombosis Lancet 338 1991 597 600
6. S.F. de Bruijn, and J. Stam Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis Stroke 30 1999 484 488
7. R.L. Sacco, R. Adams, and G. Albers Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline Stroke 37 2006 577 617
8. M. Gattellari, J. Worthington, and N. Zwar Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: A representative survey of Australian family physicians Stroke 39 2008 227 230
9. B.I. Eriksson, D.J. Quinlan, and J.W. Eikelboom Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism Annu Rev Med 62 2011 41 57
10. J. Stangier, B.I. Eriksson, and O.E. Dahl Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement J Clin Pharmacol 45 2005 555 563
11. G. Saposnik, F. Barinagarrementeria, and R.D. Brown Jr. Diagnosis and management of cerebral venous thrombosis: A statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 42 2011 1158 1192
12. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151